Feng Jiheng, Shen Chenjun, Tian Shasha, Chen Xingcan, Zhou Fangmei, Zhou Mingyuan, Zhu Bingqi, Li Xiaoyan, Ding Zhishan
School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China.
School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China.
Fitoterapia. 2024 Oct;178:106175. doi: 10.1016/j.fitote.2024.106175. Epub 2024 Aug 15.
The traditional Chinese medicine Tetrastigma Hemsleyanum (TH) is employed in treating respiratory diseases; however, the aerial parts by which its total flavonoids alleviate acute lung injury (ALI) are still unknown. This study investigated the protective effect and mechanism of Tetrastigma Hemsleyanum flavonoids (THF) in lipopolysaccharide (LPS)-induced ALI in mice.
Firstly, the total flavonoids from the above-ground part of TH were extracted. Subsequently, the composition of THF was analyzed using LC-MS. In vivo, the impact of THF on ALI mice was assessed through lung histopathology and the evaluation of various inflammatory factors' expression in mice. After treating RAW264.7 cells with THF in vitro, changes in inflammatory markers were examined upon LPS stimulation, and mRNA expression levels of inflammatory factors were detected using RT-qPCR. Finally, Western blot analysis was performed to determine TLR4/NF-κB pathway-associated proteins expression.
In summary, a total of 24 flavonoids have been identified in THF. In vivo and vitro results show that THF effectively reduces the damage caused by LPS inflammation by blocking the expression and release of inflammatory factors. THF alleviates inflammatory injury by modulating the TLR4/NF-KB pathway.
The results suggest that flavonoids exhibit a potent anti-inflammatory effect and effectively mitigate LPS-induced injury both in vivo and in vitro. We suggested that these flavonoids exert their therapeutic effects by modulating the TLR4/NF-KB pathway. In conclusion, the development of THF is anticipated to represent a promising new pharmaceutical for treatingALI.
中药三叶崖爬藤(TH)用于治疗呼吸道疾病;然而,其总黄酮减轻急性肺损伤(ALI)的地上部分仍不清楚。本研究探讨了三叶崖爬藤黄酮(THF)对脂多糖(LPS)诱导的小鼠ALI的保护作用及机制。
首先,提取三叶崖爬藤地上部分的总黄酮。随后,采用液相色谱-质谱联用(LC-MS)分析THF的成分。在体内,通过肺组织病理学和评估小鼠体内各种炎症因子的表达来评估THF对ALI小鼠的影响。在体外,用THF处理RAW264.7细胞后,检测LPS刺激后炎症标志物的变化,并使用逆转录定量聚合酶链反应(RT-qPCR)检测炎症因子的mRNA表达水平。最后,进行蛋白质免疫印迹分析以确定Toll样受体4(TLR4)/核因子κB(NF-κB)信号通路相关蛋白的表达。
总之,在THF中总共鉴定出24种黄酮类化合物。体内和体外实验结果表明,THF通过阻断炎症因子的表达和释放有效减轻LPS炎症引起的损伤。THF通过调节TLR4/NF-κB信号通路减轻炎症损伤。
结果表明,黄酮类化合物具有强大的抗炎作用,在体内和体外均能有效减轻LPS诱导的损伤。我们认为这些黄酮类化合物通过调节TLR4/NF-κB信号通路发挥治疗作用。总之,预计THF的开发将成为一种有前景的治疗ALI的新型药物。